Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03598270
Title Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer (ANITA)
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Grupo Espanol de Investigacion en Cancer de Ovario
Indications

fallopian tube carcinoma

peritoneal carcinoma

endometrioid ovary carcinoma

ovarian serous carcinoma

Therapies

Carboplatin + Gemcitabine

Niraparib

Carboplatin + Pegylated liposomal-doxorubicin

Atezolizumab + Carboplatin + Pegylated liposomal-doxorubicin

Atezolizumab + Carboplatin + Gemcitabine

Atezolizumab + Carboplatin + Paclitaxel

Carboplatin + Paclitaxel

Atezolizumab + Niraparib

Age Groups: adult | senior
Covered Countries


No variant requirements are available.